Pre-exposure Prophylaxis Clinical Trials in New York, New York
2 recruitingNew York, New York
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)
HIV Pre-Exposure Prophylaxis
Gilead Sciences350 enrolled31 locationsNCT07047716
Recruiting
Not Applicable
Stick2PrEP Cisgender Women and Trans Individuals
HIV PreventionPre-exposure Prophylaxis
Columbia University175 enrolled1 locationNCT05165745